Ilyang Pharmaceutical
일양약품KRX: 007570· Fiscal year 2025· ilyang.co.kr ↗
Average salary
$63.6K
₩84.7M
▲ 10.3% vs 2024
Employees
665
▼ 0.4% vs 2024
Average tenure
9.7 yrs
Estimated take-home of this pay:$4.2K / monthCalculate →
Workplace
Women's pay (men = 100)50
Women among staff20.6%
Contract staff0.3%
Recent official filings
- 2026-11-16Quarterly report (2026.09)
- 2026-09-09Supply contract terminated
- 2026-08-14Half-year report (2026.06)
- 2026-07-30MajorChange of largest shareholder
- 2026-07-30MajorChange of largest shareholder
Quick read
- Average pay is 39% above the median of the companies we track.
- Average pay rose 10.3% from 2024.
- Headcount shrank by 3 (0.4%) from 2024.
- Ranks #16 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue grew 1.4% year over year.
- Revenue has grown two years in a row.
- Operating margin was 1.8% in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $306.7K
- Net profit per employee
- $8.0K
- Operating margin
- 1.8%
- Net margin
- 2.6%
- ROE
- 3.0%
- Debt-to-equity
- 89.4%
- Equity ratio
- 52.8%
- Payout ratio
- 41.4%
- Dividend per share
- $0
- Dividend yield (as disclosed)
- 1.2%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.